科普專欄–薯不揀單 - 深入淺出–以免疫治療(Immunotherapy)手段醫治癌細胞(二)

上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性，接下來我們將會繼續深入探討問題。1342Please respect copyright.ＰＥＮＡＮＡDveY89TeaS
1342Please respect copyright.ＰＥＮＡＮＡqkHswdhhsf
上集：https://www.penana.com/article/4711251342Please respect copyright.ＰＥＮＡＮＡLO8NhneSxg
1342Please respect copyright.ＰＥＮＡＮＡagbOisRLCM
1342Please respect copyright.ＰＥＮＡＮＡfVG97lvBMD
1342Please respect copyright.ＰＥＮＡＮＡ0SrQ1eTPky
（圖1）雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力，但另一個重要的問題是，如何確保有足夠的T cell殺滅癌細胞呢?1342Please respect copyright.ＰＥＮＡＮＡ3dJaaUGnne
1342Please respect copyright.ＰＥＮＡＮＡKciC3uwHzi
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物，但免疫系統細胞數量不足的話，依然是不會達到重大效果的。1342Please respect copyright.ＰＥＮＡＮＡ5iOC4N1JbA
1342Please respect copyright.ＰＥＮＡＮＡErITmG5Pc1
換句話說，我們需要一道能夠提升針對癌細胞的T cell數量手段。1342Please respect copyright.ＰＥＮＡＮＡakkzDHYHhY
1342Please respect copyright.ＰＥＮＡＮＡ2nIKUfd1f6
1342Please respect copyright.ＰＥＮＡＮＡo7UXaUKtTW
1342Please respect copyright.ＰＥＮＡＮＡZwn7EhKkGr
（圖2）T cell的產生數量，接近可以說是由Antigen Presenting Cells(APC)來決定;1342Please respect copyright.ＰＥＮＡＮＡnCTYybVJ6F
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1342Please respect copyright.ＰＥＮＡＮＡUkDCtNDh7F
1342Please respect copyright.ＰＥＮＡＮＡx4MnxH1HQ7
忘記甚麼是Neoantigen的話，可重溫上一集。1342Please respect copyright.ＰＥＮＡＮＡjJyHt85FJO
1342Please respect copyright.ＰＥＮＡＮＡiQelJiIXu6
當APC展示癌細胞的Neoantigen予T cell的receptor後，另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1342Please respect copyright.ＰＥＮＡＮＡIt7ONxxrvH
1342Please respect copyright.ＰＥＮＡＮＡBnY03BZuPR
只要兩者條件達成的話，負責對付對應癌細胞的T cell數量及效力便會大增。1342Please respect copyright.ＰＥＮＡＮＡJ3cKzdKXrI
1342Please respect copyright.ＰＥＮＡＮＡcojzooOKIT
1342Please respect copyright.ＰＥＮＡＮＡrCYS7qHoHG
1342Please respect copyright.ＰＥＮＡＮＡgb04RPtHSU
（圖3）然而，當T cell數量產生至一定程度的時候，T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置，與B7合併。1342Please respect copyright.ＰＥＮＡＮＡcdp1fh6feo
1342Please respect copyright.ＰＥＮＡＮＡeuBDm8zxR3
而當CTLA4與B7合併後，T cell所產生的數量及威力就會大減。1342Please respect copyright.ＰＥＮＡＮＡMMgioYz7DZ
1342Please respect copyright.ＰＥＮＡＮＡjdr65peU9P
這個CTLA4產生的機制是與生俱來的，目的就是為了避免產生過量的T cell，以免身體會產生不良反應。1342Please respect copyright.ＰＥＮＡＮＡ8ipA4puO1E
1342Please respect copyright.ＰＥＮＡＮＡB4OYNzusHK
1342Please respect copyright.ＰＥＮＡＮＡ7WRVI6n7e4
（圖4）只不過的是，現時癌細胞大敵當前，燃眉之急就是要調動大量的T cell前往討伐癌細胞。1342Please respect copyright.ＰＥＮＡＮＡ6Tgb1JbM57
1342Please respect copyright.ＰＥＮＡＮＡDwx5a6x3Ti
為此，我們重施應對PD1/PDL1故技，利用抗體阻擋CTLA4，確保CD28及B7持續合併，不斷產生效力高強的T cell。1342Please respect copyright.ＰＥＮＡＮＡ81ZrPYav2G
1342Please respect copyright.ＰＥＮＡＮＡuOPYo5Vad9
1342Please respect copyright.ＰＥＮＡＮＡ4qiDlaiZqP
（圖5）簡略的總結來說，為了確保有足夠的T cell消滅癌細胞，我們不惜採用阻擋CTLA4的抗體，號令身體持續產生效力高強的T cell。1342Please respect copyright.ＰＥＮＡＮＡ8JM2gnGZ2H
而另一邊廂，我們亦同時利用阻擋PD1/PDL1的抗體，確保T cell能夠順利把癌細胞辨認成為外來物，將其制裁。1342Please respect copyright.ＰＥＮＡＮＡUPw28lP91Y
1342Please respect copyright.ＰＥＮＡＮＡtROkwLiH78
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法，將能大大提升免疫治療的效率。1342Please respect copyright.ＰＥＮＡＮＡbKUu8yMdMV
1342Please respect copyright.ＰＥＮＡＮＡdcZK2W0PUd
但是，並不是所有病人也能依靠這方法而得益，原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1342Please respect copyright.ＰＥＮＡＮＡhBn9Kxsv3T
1342Please respect copyright.ＰＥＮＡＮＡaDOLXZZi2R
這一方面，我們將會在下一篇免疫治療的最終章再作探討。1342Please respect copyright.ＰＥＮＡＮＡyReUQiR3aO
1342Please respect copyright.ＰＥＮＡＮＡ9CZVcMeNer
1342Please respect copyright.ＰＥＮＡＮＡkvYXtMwEpn
如果想我快啲出文的話，請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark，這對我非常之重要。1342Please respect copyright.ＰＥＮＡＮＡROLk5gJoUk
1342Please respect copyright.ＰＥＮＡＮＡme4eALau65
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1342Please respect copyright.ＰＥＮＡＮＡ6vTDVp46Oh
1342Please respect copyright.ＰＥＮＡＮＡmrZULNtPKS
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」，以課金的方式推動我繼續搜羅資料寫文，多謝。1342Please respect copyright.ＰＥＮＡＮＡXxx60Yxjux
1342Please respect copyright.ＰＥＮＡＮＡcekDWjfS1S
Link:1342Please respect copyright.ＰＥＮＡＮＡPIIoItxHti
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1342Please respect copyright.ＰＥＮＡＮＡ3zrYDWdFcZ
1342Please respect copyright.ＰＥＮＡＮＡMdNXuTfGqc
1342Please respect copyright.ＰＥＮＡＮＡ1FxRGzsVN6
有興趣接收科普資訊的話，歡迎follow IG: potatopigtongue。1342Please respect copyright.ＰＥＮＡＮＡdzbXfuwptU